Table of Contents
ISRN Endocrinology
Volume 2013, Article ID 346987, 5 pages
http://dx.doi.org/10.1155/2013/346987
Research Article

Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice

1Laboratory of Immunobiology for Research and Diagnosis (LIRAD-BST), Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, 08916 Badalona, Spain
2Department of Endocrinology, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, 08916 Badalona, Spain
3Immunology Unit, Department of Ciencies Basiques Mediques, Faculty of Medicine, University of Lleida & IRBLleida, 25198 Lleida, Spain

Received 6 February 2013; Accepted 22 February 2013

Academic Editors: C. Anderwald and H.-Q. Qu

Copyright © 2013 Irma Pujol-Autonell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Bach and L. Chatenoud, “Tolerance to islet autoantigens in type 1 diabetes,” Annual Review of Immunology, vol. 19, pp. 131–161, 2001. View at Google Scholar
  2. S. Marin-Gallen, X. Clemente-Casares, R. Planas et al., “Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes,” Clinical and Experimental Immunology, vol. 160, no. 2, pp. 207–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Chatenoud, J. Primo, and J. F. Bach, “CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice,” Journal of Immunology, vol. 158, no. 6, pp. 2947–2954, 1997. View at Google Scholar · View at Scopus
  4. S. Tsai, A. Shameli, J. Yamanouchi et al., “Reversal of autoimmunity by boosting memory-like autoregulatory T cells,” Immunity, vol. 32, no. 4, pp. 568–580, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Ponticelli, “The pleiotropic effects of mTor inhibitors,” Journal of Nephrology, vol. 17, no. 6, pp. 762–768, 2004. View at Google Scholar
  6. P. Monti, M. Scirpoli, P. Maffi et al., “Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells,” Diabetes, vol. 57, no. 9, pp. 2341–2347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Hamaguchi, H. R. Gaskins, and E. H. Leiter, “NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse,” Diabetes, vol. 40, no. 7, pp. 842–849, 1991. View at Google Scholar · View at Scopus
  8. L. K. M. Shoda, D. L. Young, S. Ramanujan et al., “A comprehensive review of interventions in the NOD mouse and implications for translation,” Immunity, vol. 23, no. 2, pp. 115–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. Chaparro and T. P. Dilorenzo, “An update on the use of NOD mice to study autoimmune (Type 1) diabetes,” Expert Review of Clinical Immunology, vol. 6, no. 6, pp. 939–955, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Johnson, Z. Ao, P. Ao et al., “Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets,” Cell Transplantation, vol. 18, no. 8, pp. 833–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rabinovitch, W. L. Suarez-Pinzon, A. M. James Shapiro, R. V. Rajotte, and R. Power, “Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice,” Diabetes, vol. 51, no. 3, pp. 638–645, 2002. View at Google Scholar · View at Scopus
  12. W. L. Baeder, J. Sredy, S. N. Sehgal, J. Y. Chang, and L. M. Adams, “Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice,” Clinical and Experimental Immunology, vol. 89, no. 2, pp. 174–178, 1992. View at Google Scholar · View at Scopus
  13. M. Belghith, J. A. Bluestone, S. Barriot, J. Mégret, J. F. Bach, and L. Chatenoud, “TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes,” Nature Medicine, vol. 9, no. 9, pp. 1202–1208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Valle, T. Jofra, A. Stabilini, M. Atkinson, M. G. Roncarolo, and M. Battaglia, “Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice,” Diabetes, vol. 58, no. 4, pp. 875–881, 2009. View at Publisher · View at Google Scholar · View at Scopus